Form 4: Neurocrine Biosciences Director Stephen Sherwin Donates 2,000 Shares to Charity
SEC Form 4 Filing
Director Stephen Sherwin of Neurocrine Biosciences donated 2,000 shares of common stock to a charitable organization on November 4, 2024.
Summary
- On November 4, 2024, Stephen Sherwin, a director of Neurocrine Biosciences Inc., donated 2,000 shares of common stock to a charitable organization.
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
- Following the transaction, Sherwin directly owns 24,504 shares of Neurocrine Biosciences common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (charitable donation) by a company director. It doesn't inherently convey positive or negative sentiment regarding the company's performance or outlook.
Industry Context
Insider transactions, such as charitable donations of stock, are common and must be reported to the SEC. These transactions can provide insights into the perspectives of company insiders, although charitable donations are often driven by personal philanthropic goals rather than company-specific factors.
Key Dates
| Date | Description |
|---|---|
| 11/04/2024 | Date of the gift/charitable contribution of 2,000 shares. |
| 11/07/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.